Human Subjects Mechanistic and Minimal Risk Studies (R21 Clinical Trial Optional)

Funder: National Institutes of Health

Due Date: 1/7/2021

Budget: Negotiable

Opportunity: PA-18-500

The purpose of this FOA is to encourage applications that seek to conduct studies of the visual system.  Applications that will be supported may be either:

  • Those that involve human subjects, but are not NIH-defined clinical trials (see NOT-OD-15-015); or
  • Those that are NIH-defined clinical trials and are designed to address either: 1) mechanisms underlying human vision in health and disease; or 2) interventions that entail procedures with minimal risk to subjects.  More information about eligibility can be found in Part 2 Section III.3.

Leave a Reply